Author: Kendyll Martin
A Ross soon-to-be graduate shares her experiences and what she learned from a study abroad trip to Hong Kong.Read More
For decades, the World Economic Forum in Davos was a symbol of global cooperation. Today, its relevance is questioned.Read More
Peculiarly, for all the talk of tech, it is really the people that make it work.Read More
A team of Carolina researchers received $400,000 to make detection and treatment affordable and accessible.Read More
SIM0505 (CDH6 ADC) Phase 1 dose escalation data update anticipated in Q2 2026LNCB74 (B7-H4 ADC) Phase 1 dose escalation expanded into higher dose cohorts BELTSVILLE, Md., Jan. 23, 2026 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to developing novel therapies to treat cancer, today provided updates for its two antibody drug conjugate (ADC) programs and reported a preliminary year-end 2025 cash position. SIM0505 (CDH6 ADC): Phase 1 dose eRead More
By Kate Holton, Andrew MacAskill and Elizabeth Piper LONDON, Jan 23 (Reuters) – British finance minister Rachel Reeves will accompany Prime Minister Keir Starmer on his trip to China next week, underscoring UK efforts to strengthen ties with the world’s second-largest economy at a time of …Read More
Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22, as the market digested weaknesses from its fourth-quarter and full-year earnings report. | Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22 as the market digested weaknesses from its fourth-quarter and full-year earnings report.Read More
SIM0505 (CDH6 ADC) Phase 1 dose escalation data update anticipated in Q2 2026LNCB74 (B7-H4 ADC) Phase 1 dose escalation expanded into higher dose cohorts BELTSVILLE, Md., Jan. 23, 2026 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to developing novel therapies to treat cancer, today provided updates for its two antibody drug conjugate (ADC) programs and reported a preliminary year-end 2025 cash position. SIM0505 (CDH6 ADC): Phase 1 dose eRead More
The Las Vegas Raiders are expected to take Mendoza with the No. 1 overall pick.Read More
In 2026, Fanatics, New Era Cap and SeatGeek could go publicRead More